IDENTIFICATION OF KEY GENES AND CONSTRUCTION OF MICRORNA-MRNA REGULATORY NETWORKS IN MULTIPLE MYELOMA BY INTEGRATED MULTIPLE GEO DATASETS USING BIOINFORMATICS ANALYSIS
EHA Library, Zuofei Chi, 182339
CYP1A1 AND CXCL12 GENE POLYMORPHISMS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Eftichia Stiakaki, 182340
INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21 IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA; A RARE SUBTYPE
EHA Library, Livia Vida, 182341
HIGH RESOLUTION TECHNOLOGIES IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Adela Escudero, 182342
COMPLETE REMISSION WITH BLINATUMOMAB IN TWO PATIENTS WITH SKIN RELAPSED B-CELL ACUTE LEUKEMIA
EHA Library, Harmony Leroy, 182343
A NOVEL METHOD FOR MINIMAL RESIDUAL DISEASE ANALYSIS IN PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: MODIFIED BIOMED-2 POLYMERASE CHAIN REACTION FOR IMMUNOGLOBULIN HEAVY CHAIN REARRANGEMENT
EHA Library, Daisuke Katoh, 182344
SYSTEMATIC LITERATURE REVIEW OF PEGASPARGASE FOR THE TREATMENT OF NEWLY DIAGNOSED ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
EHA Library, Ellen Hooper, 182345
A COMPREHENSIVE ANALYSIS OF PATIENT- AND THERAPY-RELATED FACTORS AFFECTING THE TOXICITY OF PEGYLATED-ASPARAGINASE FOR THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Paola Minetto, 182346
COST OF CARE FOR ADULT PATIENTS WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA WITH AND WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANT IN GERMANY
EHA Library, Jin Kyung Suh, 182347
RETROSPECTIVE STUDY OF ADULT ALL IN MEXICO CITY: FIRST REPORT OF THE WORKING GROUP ON ACUTE LEUKEMIA (GTLA).
EHA Library, Erick Crespo-Solís, 182348
IMPACT OF DISEASE STATUS ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC LEUKEMI
EHA Library, Xiaowen Tang, 182349
THE FREQUENCY AND PROGNOSTIC SIGNIFICANCE OF IKZF1 DELETIONS IN ADULT PH-POSITIVE AND PH-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED IN RUSSIAN ACUTE LYMPHOBLASTIC LEUKEMIA STUDIES.
EHA Library, Galina Isinova, 182350
GMALL BASED PROTOCOL, USING NATIVE E. COLI L-ASPARAGINASE, IMPROVES SURVIVAL OF ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN BRAZIL
EHA Library, Ingrid Arcuri, 182351
THE INVESTIGATION OF RELATIONSHIP BETWEEN COL1A1 AND FOK1 GENE POLYMORPHISMS AND DEVELOPMENT OF TREATMENT-RELATED SKELETAL COMPLICATIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ozlem Tufekci, 182352
OUTCOME OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL: MONOCENTRIC STUDY
EHA Library, Imen Frikha, 182353
ASSESSMENT OF DEPRESSION AND SELF-CONCEPTION IN CHILDREN WITH ALL-TREATMENT
EHA Library, Gonul AYDOGAN, 182354
SEVERE PSYCHIATRIC DISTURBANCES DURING THERAPY IN PEDIATRIC ALL
EHA Library, Charoula Tsipou, 182355
INCIDENCE, SEVERITY AND RISK FACTORS FOR NEUROLOGIC COMPLICATIONS ASSOCIATED WITH L ASPARAGINASE TREATMENT IN PAEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Library, Mihaela Georgiana Safta, 182356
INCIDENCE AND SURVIVAL OF CHILDHOOD LEUKEMIA IN ARMENIA: A POPULATION-BASED ANALYSIS
EHA Library, Mareza Tatulyan, 182357
LONG-TERM SURVIVAL OUTCOMES OF ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH IMATINIB OR DASATINIB
EHA Library, Golnaz Vahdani, 182358
OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A MIXED COHORT OF PEDIATRIC AND ADULT PATIENTS WITH KMT2A-AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Tatiana Gindina, 182359
DERMATOLOGIC COMPLICATIONS ASSOCIATED WITH TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF ACUTE LEUKEMIA.
EHA Library, Ksenija Zarubina, 182360
CYTOKINE RELEASE SYNDROME AFTER THE FIRST INTRATHECAL CHEMOTHERAPY IN A PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN EARLY MENINGEAL RELAPSE
EHA Library, Fara Petruzziello, 182361
SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH IMATINIB AND PREDNISONE THERAPY IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Mariarita Sciumè, 182362
LATE EFFECTS OF CHEMORADIOTHERAPY ON THE ENDOCRINE SYSTEM IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Gonul AYDOGAN, 182363
MUTATIONAL ANALYSIS OF 231 DE NOVO AML PATIENTS BELOW 60 YEARS WITH CURATIVE THERAPY
EHA Library, Adam Folta, 182364
INHIBITION OF LIN28B IMPAIRS LEUKEMIA CELL GROWTH AND METABOLISM IN ACUTE MYELOID LEUKEMIA
EHA Library, Jianbiao Zhou, 182365
EVALUATION OF MINIMAL RESIDUAL DISEASE IN NPM1-MUTATED AML PATIENTS.
EHA Library, Carolina Martínez-Laperche, 182367
AT101 ELIMINATES AML STEM CELLS VIA ACTIVATION OF INTRINSIC APOPTOTIC PATHWAY AND PARTICIPATION IN DNA DAMAGE RESPONSE
EHA Library, Bing Xu, 182368
COOPERATIVE EFFECT OF CHIDAMIDE AND CHEMOTHERAPEUTIC DRUGS INDUCE APOPTOSIS BY DNA DAMAGE ACCUMULATION AND REPAIR DEFECTS IN ACUTE MYELOID LEUKEMIA STEM AND PROGENITOR CELLS
EHA Library, Bing Xu, 182369
NEW CANDIDATE GENES USEFUL TO PREDICT THE RISK OF RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA
EHA Library, Jacopo Nanni, 182371
THE EXPRESSION OF SALL4 AND BMI-1 GENES IN MYELOID LEUKEMIA
EHA Library, Mona El-Nagdy, 182372
AN INVESTIGATION INTO THE ROLE OF S100A8 AND S100A9 IN ACUTE MYELOID LEUKAEMIA
EHA Library, Sabah Chaudry, 182373
SUCCESSFUL COVERAGE OF DIFFICULT TO SEQUENCE GENES (CALR, CEBPA, AND FLT3) ASSOCIATED WITH MYELOID DISORDERS USING A HYBRIDISATION-BASED ENRICHMENT APPROACH PRIOR TO NEXT-GENERATION SEQUENCING (NGS).
EHA Library, Graham Speight, 182374
ASSOCIATION OF MIRNA EXPRESSION PROFILES WITH FUNCTIONAL AND MOLECULAR ACUTE MYELOID LEUKEMIA CATEGORIES
EHA Library, *Claudia Sargas, 182375
PROTEOMIC APPROACH TO IDENTIFY MOLECULAR TARGETS OF HALOFUGINONE IN ACUTE MYELOID LEUKEMIA
EHA Library, Larissa Cândido, 182376
DNA METHYLATION AND HYDROXYMETHYLATION PROFILING IS CAPABLE TO DISTINGUISH AML SAMPLES WITH DISTINCT MUTATIONS IN DNA METHYLATION REGULATORY GENES
EHA Library, Hana Hájková, 182377
RNA-MEDIATED CORRECTION OF ABERRANT DNA METHYLATION AT THE P15 LOCUS
EHA Library, Mailin Li, 182378
JQ1 AND CURCUMIN COMBINED TREATMENT SHOWS SYNERGIC EFFECTS IN MLL-REARRANGED LEUKEMIA CELL LINES
EHA Library, Patrizia Vitullo, 182379
TP53Β AND TP53Γ EXPRESSION LEVELS IN RELATION TO NPM1 AND CEBPA MUTATIONS.
EHA Library, Karolina Matiakowska, 182380
EXPRESSION PROFILE OF EPIGENETIC MODULATORS IN ACUTE MYELOID LEUKEMIA OF INTERMEDIATE RISK
EHA Library, Santiago Sánchez Sosa, 182381
FLOW CYTOMETRY IMMUNOPHENOTYPING IN CEBPA-DM DE NOVO AML. BIOLOGIC AND PROGNOSTIC RELEVANCE.
EHA Library, Monica Fernandez, 182382
PROTEOME CHANGES IN ACUTE MYELOID LEUKEMIA PATIENTS BEFORE AND AFTER INDUCTION TREATMENT
EHA Library, Luisa , 182383
AMP-ACTIVATED PROTEIN KINASE ACTIVITY INTERFERES WITH OVEREXPRESSION OF NUCLEOPHOSMIN IN CYTARABINE-INDUCED CHEMORESISTANT AML CELLS
EHA Library, Dana Kim, 182384
QUERCETIN REGULATES TELOMERE-BINDING PROTEINS EXPRESSION OF POT1, TRF1, TRF2 TO INHIBIT PROLIFERATION AND INDUCE APOPTOSIS IN AML THP-1 CELLS
EHA Library, Ruirong Xu, 182385
PPARΓ AGONISTS INHIBIT ADHESION SIGNAL TO ENDOTHELIAL CELLS IN THE DIFFERENTIATION INDUCTION OF HL-60 ACUTE PROMYELOCYTIC LEUKEMIA CELLS.
EHA Library, Jinny Park, 182386
IN VITRO DRUG SENSITIVITY TEST IN THE INDIVIDUALIZED ANTI-LEUKEMIA CHEMOTHERAPY FOR THE NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EHA Library, Sungnam Lim, 182387
PROGNOSTIC IMPACT OF P53 EXPRESSION IN BONE MARROW BIOPSY OF PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, Heloíza Souza, 182388
LONG-TERM FOLLOW-UP OF SALVAGE TREATMENT FOR RELAPSED AML WITH CLADRIBINE, HIGH DOSE CYTARABINE AND IDARUBICIN (CAI)
EHA Library, Karin Mayer, 182390
HIGH EVI1 EXPRESSION PREDICTS POOR OUTCOMES IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH INTERMEDIATE CYTOGENETIC RISK RECEIVING CHEMOTHERAPY ONLY
EHA Library, Qianli Jiang, 182391
EFFICACY AND SAFETY OF DECITABINE IN ELDERLY AML PATIENTS: A REAL LIFE MULTICENTER EXPERIENCE OF THE NETWORK RETE EMATOLOGICA LOMBARDA (REL)
EHA Library, Erika BORLENGHI, 182392
CLOFARABINE, CYTARABINE AND MITOXANTRONE (CLAM) FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA - INTERIM RESULTS OF A PROSPECTIVE PHASE 2 STUDY
EHA Library, Harinder Gill, 182393
FATAL EVOLUTION IN THE FIRST 96 HOURS OF PATIENTS DIAGNOSED WITH ACUTE LEUKEMIA: ANALYSIS OF A SERIES OF 346 CONSECUTIVE CASES OF ACUTE LEUKEMIA IN A SINGLE CENTER
EHA Library, Silvia Martin-Batista, 182394
PRIMARY POSACONAZOLE PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA - A SINGLE CENTER REAL LIFE EXPERIENCE
EHA Library, Tülin Fıratlı Tuğlular, 182395
CLINICAL AND PROGNOSTIC VALUE OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS IN ROUTINE CLINICAL PRACTICE - SINGLE CENTER EXPERIENCE
EHA Library, Asiyat Radzhabova, 182396
TARGETING ENDOTHELIAL DYSFUNCTION FOR PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA AND CO-MORBID ISCHEMIC HEART DISEASE
EHA Library, Tetiana Lymanets, 182397
CLINICAL CHARACTERISTICS AND SURVIVAL OUTCOMES IN ACUTE ERYTHROID LEUKEMIA (AML-M6): AML/MDS WORKING PARTY STUDY OF KOREAN SOCIETY OF HEMATOLOGY
EHA Library, Jae Joon Han, 182398
PREGNANCY ACCUMULATES UNFAVORABLE MOLECULAR GENETIC AML AND SHOULD BE CONSIDERED AS A POOR PROGNOSTIC FACTOR.
EHA Library, Vera Troitskaya, 182399
CLOFARABINE IN RELAPSED-REFRACTORY ACUTE MYELOGENOUS LEUKEMIA: A SINGLE CENTRE EXPERIENCE
EHA Library, Barbara Scappini, 182400
PRESENCE OF MULTIPLE DRIVERS IN THE SELECTION OF HIGH AND LOW INTENSITY CHEMOTHERAPY IN AML
EHA Library, Kalpana Vijayan, 182401
IRAIN LONG NON CODING RNA ARE DOWN-REGULATED IN POOR PROGNOSIS AML PATIENTS
EHA Library, Marjan Yaghmaie, 182402
PERFORMANCE OF THE LEUKOSTRAT® CDX FLT3 MUTATION SIGNAL RATIO ASSAY TO DETECT INTERNAL TANDEM DUPLICATION (ITD) AND TYROSINE KINASE DOMAIN (TKD) MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
EHA Library, April Osgood, 182403
CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA
EHA Library, Souad Taoussi, 182404
FLOW CYTOMETRY ANALYSIS SOFTWARE FOR REMOTELY LOCATED HAEMATOLOGISTS
EHA Library, Mark Kelly, 182405
FLAG-IDA IN THE TREATMENT OF ACUTE LEUKEMIA: SINGLE-CENTER EXPERIENCE
EHA Library, Maria Isabel Goyanes, 182406
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS - UNUSUAL PRESENTATIONS AND UNFAVOURABLE OUTCOMES
EHA Library, Margarita Guenova, 182407
PREDICTIVE RELEVANCE OF CLINICAL CHARACTERISTICS IN PEDIATRIC PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA TREATED AT SINGLE INSTITUTION- REPORT OF AN OUTCOME ANALYSIS.
EHA Library, Suleimman Alsweedan, 182408
IS HIF-2 ALPHA A POOR PROGNOSIS FACTOR IN HUMAN ACUTE MYELOID LEUKEMIA? A SINGLE CENTER ANALYSIS - PRELIMINARY RESULTS
EHA Library, Jarosław Dybko, 182409
RARE BCR/ABL FUSION PROTEINS AND THEIR CLINICAL SIGNIFICANCE INTO PH+ ACUTE MYELOID LEUKEMIAS
EHA Library, Monica Piedimonte, 182410
HYPOMETILATING AGENTS (HMA) AS SALVAGE THERAPY IN RELAPSED OR REFRACTORY AML: A 2-CENTERS RETROSPECTIVE STUDY
EHA Library, Federica Lessi, 182411
OMITTING CYTARABINE FROM CHEMOTHERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA REDUCES TOXICITY AND NOT EFFICACY
EHA Library, Eleni Gavriilaki, 182412
DISEASE CHARACTERISTICS AND TREATMENT PATTERNS OF AML PATIENTS <60 YEARS OLD VERSUS ≥60 YEARS OLD
EHA Library, Kalpana Vijayan, 182413
FLT3, NPM1, СЕВРА AND ТР53 MUTATIONS AT ACUTE PROMYELOCYTIC LEUKEMIA: PROGNOSTIC FACTORS AND CORRELATION WITH OTHER MARKERS WITHIN THE PATIENTS OF GOMEL REGION IN BELARUS
EHA Library, Zhanna Kozich, 182414
A UNIQUE PRESENTATION OF ACUTE PROMYELOCYTIC LEUKEMIA: AORTOILIAC OCCLUSIVE DISEASE (LERICHE SYNDROME)
EHA Library, Selin Berk, 182415
A CASE OF THERAPY-RELATED ACUTE LEUKEMIA WITH MIXED PHENOTYPE WITH BCR-ABL1 AFTER TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Dahae Yang, 182416
CROSS-SECTIONAL ANALYSIS OF CONCORDANCE RATES BETWEEN KARYOTYPING AND RT-PCR IN ACUTE MYELOID LEUKEMIA; REAL WORLD CHALLENGES
EHA Library, Deeksha Katoch, 182417
CLINICAL, CYTOMORPHOLOGIC AND IMMUNOPHENO/IMMUNOHISTOCHEMICAL CHARACTERISTICS OF PATIENTS WITH BLASTIC PLASMOCYTOID DENDRITIC CELL NEOPLASM - DIAGNOSTIC AND THERAPEUTIC DILEMMA
EHA Library, Jelena Bila, 182418
ECONOMIC IMPACT AND HEALTHCARE UTILIZATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN ROUTINE CLINICAL CARE IN THE UNITED STATES (US) - A CLAIMS DATABASE STUDY
EHA Library, Aaron Galaznik, 182419
PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, B. Jezersek Novakovic, 182420
HOW 18FDG PET/CT CAN IDENTIFY BONE MARROW INFILTRATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
EHA Library, Stefania Leone, 182421
LOW ALBUMIN LEVEL CORRELATES WITH POORER SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: SERBIAN LYMPHOMA GROUP EXPERIENCE
EHA Library, Jelena Jelicic, 182422
TREATMENT PATTERNS AND TREATMENT RESPONSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN ROUTINE CLINICAL CARE IN THE UNITED STATES (US) - A CLAIMS DATABASE STUDY
EHA Library, Aaron Galaznik, 182423
TP53 GENE MUTATIONS IS A PREDICTOR OF HIGH GRADE B-CELL LYMPHOMA PROGRESSION
EHA Library, Anna Misyurina, 182424
HTLV-1 INFECTION INCREASED THE RISK OF OTHER MALIGNANCY
EHA Library, Aya Nakaya, 182425
THIOTEPA BUSULFAN CYCLOPHOSPHAMIDE (TBC), A TOXIC CONDITIONING FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) IN CENTRAL NERVOUS SYSTEM LYMPHOMA (CNSL): REMISSION OR INFECTION?
EHA Library, Lebon Delphine, 182427
TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH RISK AND HIGH-INTERMEDIATE RISK GROUPS
EHA Library, Iryna Kriachok, 182428
PROGNOSTIC MODEL WITH NEUTROPHIL-LYMPHOCYTE RATIO AND PERFORMANCE STATUS IN DIFFUSE LARGE B CELL LYMPHOMA TREATED WITH R-CHOP
EHA Library, Gyeong-Won Lee, 182429
HIGH SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR ARE ASSOCIATED WITH A POOR PROGNOSIS IN CASES OF RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
EHA Library, Mari Morita, 182430
AUTOIMMUNE DISEASES ARE NOT ASSOCIATED WITH INFERIOR PROGNOSIS IN LYMPHOMA PATIENTS
EHA Library, Yu-Hsuan Shih, 182431
THE DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS OF CIRCULATING MIRNA-21 IN A SAMPLE OF HEPATITIS C/NONEHEPATITIS DIFFUSE LARGE B-CELL LYMPHOMAEGYPTIAN PATIENTS
EHA Library, Mayada A. Moussa, 182432
A NEW SCORING SYSTEM FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA - A RETROSPECTIVE MULTI-CENTER ANALYSIS IN TAIWAN
EHA Library, Yung-Cheng Su, 182433
RELEVANCE OF CIRS SCALE IN THE PROGNOSIS OF DIFFUSE LARGE B CELL LYMPHOMA IN ELDERLY PATIENTS
EHA Library, Carlos Plaza Meneses, 182434
PRIMARY ADRENAL LYMPHOMA: A SINGLE-CENTER EXPERIENCE
EHA Library, LEI YUAN, 182435
EFFICACY AND SAFETY OF IBRUTINIB THERAPY IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN REAL-LIFE - A MULTICENTRIC STUDY (R.E.P. - APULIAN HEMATOLOGY NETWORK)
EHA Library, Vito Pier Gagliardi, 182436
HEMATOLOGICAL MALIGNANCIES IN SOLID ORGAN TRANSPLANT RECIPIENTS: RETROSPECTIVE SINGLE-CENTER ANALYSIS IN JAPAN
EHA Library, Katsuya Fujimoto, 182437
MYC REARRANGEMENT HAS A STRONG PROGNOSTIC IMPACT IN THE FEMALE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Hideaki Nitta, 182438
ASSESSING THE RISK FOR PERFORATION IN DIFFUSE LARGE B-CELL LYMPHOMA INVOLVING THE INTESTINES USING COMPUTED TOMOGRAPHY CHARACTERISTICS.
EHA Library, Nadav Sarid, 182439
DOUBLE-HIT AND TRIPLE-HIT LYMPHOMAS: TREATMENT AND CLINICAL OUTCOME IN A SINGLE INSTITUTION
EHA Library, Laia Martínez Serra, 182440
EFFECTIVE TREATMENTS ARE REQUIRED FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WITH PRIMARY REFRACTORY DISEASE
EHA Library, Maria Queralt Salas Gay, 182441
RBAC (RITUXIMAB BENDAMUSTINE CYTARABINE) IS A FEASIBLE AND SAFE INDUCTION REGIMEN PRIOR TO ASCT IN FRONTLINE MCL: A SINGLE CENTER RETROSPECTIVE REAL LIFE EVALUATION
EHA Library, Mitja Nabergoj, 182442

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings